Abstract
Herpes simplex virus (HSV) infections are common and widespread; nevertheless, their outcome can be of unpredictable prognosis in neonates and in immunosuppressed patients. Anti-HSV therapy is effective, but the emergence of drug-resistant strains or the drug toxicity that hamper the treatment is of great concern. Vaccine has not yet shown relevant benefit; therefore, palliative prophylactic measures have been adopted to prevent diseases. This short review proposes to present concisely the history of HSV, its taxonomy, physical structure, and replication and to explore the pathogenesis of the infection, clinical manifestations, laboratory diagnosis, treatment, prophylaxis and epidemiology of the diseases.
Similar content being viewed by others
Change history
28 July 2017
An erratum to this article has been published.
References
Arduino PG, Porter SR (2008) Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med 37:107–121
Brown AEC, Cohen MN, Tong S, Braverman RS, Roonev JF, Giller R, Levin MJ (2015) Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother 59:3718–3725
Butel JS (2012) Herpesvírus. In: Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA (eds) Microbiologia Médica de Jawetz, Melnick e Adelberg, 25th edn. AMGH, Porto Alegre, pp. 433–455
Cardone G, Heymann JB, Cheng N, Trus BL, Steven AC (2012) Procapsid assembly, maturation, nuclear exit: dynamic steps in the production of infectious herpesvirions. Adv Exp Med Biol 726:423–439
Cardozo FT, Larsen IV, Carballo EV, Jose G, Stern RA, Brummel RC, Camelini CM, Rossi MJ, Simões CM, Brandt CR (2013) In vivo anti-herpes simplex virus activity of a sulfated derivate of Agaricus brasiliensis mycelial polysaccharide. Antimicrob Agents Chemother 57:2541–2549
Chentoufi AA, Kritzer E, Yu DM, Nesburn AB, Benmohamed L (2012) Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown. Clin Dev Immunol 1:1–16
Di Giovine P, Settembre EC, Bhargava AK, Luftig MA, Lou H, Cohen GH, Eisenberg RJ, Krummenacher C, Carfi A (2011) Structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1. PLoS Patog 7:1–13
Espada SF, Faccin-Galhardi LC, Rincão VP, Bernardi ALS, Lopes N, Longhini R, Mello JCP, Linhares REC, Nozawa C (2015) Antiviral activity of Trichilia catigua bark extracts for herpesvirus and poliovirus. Curr Pharm Biotechnol 16:1–9
Frobert E, Burrel S, Ducastelle-Lepretere S, Billaud G, Ader F, Casalegno JS, Nave V, Boutolleau D, Michallet M, Lina B, Morfin F (2014) Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France. Antivir Res 111:36–41
Geller M, Neto MS, Ribeiro MG, Oliveira L, Naliato ECO, Abreu C, Schechtman RC (2012) Herpes simples: atualização clínica, epidemiológica e terapêutica. J Bras Doenças Sex Transm 24:260–266
Kim J (2011) Herpes simplex virus type 1 glycoprotein gm and the membrane associated protein UL11 are required for virus-induced cell fusion and efficient virus entry. Dissertation, Konkuk University
Kimberlin DW, Whitley RJ (2007) Antiviral therapy of HSV-1 and HSV-2. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis, 1st edn. Cambridge University Press, Cambridge, pp. 1153–1174
Knipe DM, Cliffe A (2008) Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6:211–221
Kukhanova MK, Korovina AN, Kochetkov SN (2014) Human herpes simplex virus: life cycle and development of inhibitors. Biochemistry 79:1635–1652
Legoff J, Péré H, Bélec L (2014) Diagnosis of genital herpes simplex virus infection in the clinical laboratory. Virol J 11:1–17
Li L, Qiu Z, Yan L, Liang F, Ye H, Cai Y, Guo W, Li Y, Yue J (2014) Herpes B virus gD interaction with its human receptor—an in silico analysis approach. Theor Biol Med Model 11:1–16
Lopes N (2012) Avaliação da atividade antiviral de um polissacarídeo sulfatado de Caesalpinia ferrea e do flavonoide quercetina contra o vírus herpes simplex tipo 1 (HSV-1). Dissertação, Universidade Estadual de Londrina
Murray PR, Rosenthal KS, Pfaller MA (2015) Medical microbiology. Elsevier, Rio de Janeiro
Penello AM, Campos BC, Simão MS, Gonçalves MS, Souza PMT, Salles RS, Pellegrini E (2010) Herpes Ggnital. J Bras Doenças Sex Transm 22:64–72
Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL (2012) Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull 38:1137–1148
Reil H, Bartlime A, Drerup J, Grewing T, Korn K (2008) Clinical validation of a new triplex real-time polymerase chain reaction assay for the detection and discrimination of herpes simplex virus types 1 and 2. J Mol Diagn 10:361–367
Roizman B, Knipe DM, Whitley RJ (2007) Herpes simplex viruses. In: Knipe DM, Howley PM (eds) Fields Virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp. 2502–2601
Roizman B, Whitley RJ (2013) An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67:355–374
Santos MPM, Morais MPLA, Fonseca DDD, Faria ABS, Silva IHM, Carvalho AAT, Leão JC (2012) Herpesvírus humano: tipos, manifestações orais e tratamento. Odontol Clín-Cient 11:191–196
Silva S, Bowers WJ (2009) Herpes virus amplicon vectors. Viruses 1:594–629
Torres NI, Castilla V, Bruttomesso AC, Eiras J, Galagovsky LR, Wachsman MB (2012) In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1. Antivir Res 95:37–48
Whitley RJ (2014) Herpes simplex virus. In: Scheld WM, Whitley RJ, Marra CM (eds) Infections of the central nervous system, 4th edn. Lippincott Williams & Wilkins, Philadelfia, pp. 137–156
Wigg MD, Miranda MMFS (2008) Viroses dermotrópicas. In: Santos NOS, Romanos MTV, Wigg MD (eds) Introdução à Virologia Humana, 2nd edn. Guanabara Koogan, Rio de Janeiro, pp. 177–211
World Health Organization (2015) Herpes simplex virus. http://www.who.int/mediacentre/factsheets/fs400/en/. Accessed 31 Jan 2016
Woster PM (2012) Antiviral agents and protease inhibitors. In: Lemke TL, Williams DA, Roche VF, Zito SW (eds) Foye’s principles of medicinal chemistry, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp. 1267–1308
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
An erratum to this article is available at https://doi.org/10.1007/s12223-017-0539-2.
Rights and permissions
About this article
Cite this article
Rechenchoski, D.Z., Faccin-Galhardi, L.C., Linhares, R.E.C. et al. Herpesvirus: an underestimated virus. Folia Microbiol 62, 151–156 (2017). https://doi.org/10.1007/s12223-016-0482-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-016-0482-7